Hostname: page-component-5c6d5d7d68-wbk2r Total loading time: 0 Render date: 2024-08-21T22:18:21.213Z Has data issue: false hasContentIssue false

The role of psychiatrist on prescription of psychotropic drugs in schizophrenic patients in a psychiatric brief hospitalization unit

Published online by Cambridge University Press:  16 April 2020

I. Lerma-Carrillo
Affiliation:
Department of Psychiatry, Dr. R. Lafora Hospital, Madrid, Spain
F. Mora Minguez
Affiliation:
Department of Psychiatry, Dr. R. Lafora Hospital, Madrid, Spain
S. de Pablo
Affiliation:
Department of Psychiatry, Dr. R. Lafora Hospital, Madrid, Spain
M. Leonor
Affiliation:
Department of Psychiatry, Dr. R. Lafora Hospital, Madrid, Spain
F. Pascual
Affiliation:
Department of Psychiatry, Dr. R. Lafora Hospital, Madrid, Spain
T. Cuevas-Duran
Affiliation:
Department of Allergy, La Paz Universitary Hospital, Madrid, Spain
J.D. Molina
Affiliation:
Department of Psychiatry, Dr. R. Lafora Hospital, Madrid, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction:

Use of antipsychotic drugs in monotherapy is considered the standard treatment for schizophrenia and other psychotic disorders. Nevertheless, exist numerous studies that show as the polypharmacy with antipsyhotics (PA) is much more frequent than it would be expected attending to experts recommendations.

Objective:

The objective is to compare the prescription habits, in reference to the PA as well as to other psychotropic drugs, of 8 psychiatrists of a Psychiatric Hospitalization Unit.

Material and methods:

Review of the psychotropic drugs prescribed as maintenance treatment in schizophrenia patients (n=200) at outcome in 2005.

Results:

55,5% of 200 studied patients were registered with PA. This frequency oscillates between 78% and the 33,3% based on the psychiatrist. The patients received an average of 3,06 (DS 1,26) of psychotropic drugs; rank between 2,69 (DS 1,10) and 3,38 (DS 0,52) in relation to the psychiatrist. As maintenance treatment at outcome, it was prescribed an average of 1.61 (DS 0.65) of antipsychotics, rank 1.33 (DS 0,49) – 2,00 (DS 0.7). 33,2% patients received anticholinergics (17,1%-100% according to psychiatrist). Benzodiazepines were prescribed to 62,2% of patients (17,1%-100%). Mood stabilizer in the 16,7% of the cases (8%-41%). It is observed that those psychiatrists who use more PA use less benzodiazepines and anticholinergics.

Conclusions:

PA extended practice in spite of therapeutic guides recommendations. Although differences between the psychiatrists from the study are observed, most of the patients have 3 psychotropic drugs as maintenance treatment at outcome: 1 or 2 antipsychotics, benzodiazepines and anticholinergic drugs.

Type
Poster Session 1: Schizophrenia and Other Psychosis
Copyright
Copyright © European Psychiatric Association 2007
Submit a response

Comments

No Comments have been published for this article.